Scenarios that move SRRK

Scholar Rock Holding Corporation - Common Stock

Scenarios that move SRRK: 2 analyses, 2 positive, 0 negative.

1. 2026-09-24 · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▲ · impact +35 · confidence low · horizon quarters
2. 2026-09-11 · FDA approves Isembyld for spinal muscular atrophy treatment — ▲ · impact +85 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing